...
search icon
pre-img

Prenetics Global Ltd, Common Stock

PRE

NMQ

$5.41

-$0.09

(-1.64%)

1D
Industry: Insurance Sector: Financials

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$66.10M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.29K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.21
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.85 L
$6.99 H
$5.41

About Prenetics Global Ltd, Common Stock

Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company's consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes multi-cancer early detection technologies. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests. Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. Additionally, it is involved in the sports distribution activities providing sports nutrition products to fitness facilities. The company operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States. more

Industry: InsuranceSector: Financials

Returns

Time FramePRESectorS&P500
1-Week Return8.2%-0.23%1.53%
1-Month Return-6.88%7.15%4.75%
3-Month Return12.47%4.15%2.77%
6-Month Return-0.18%20.09%12.18%
1-Year Return6.08%32.23%22.34%
3-Year Return-95.3%30.36%38.91%
5-Year Return-95.36%65.86%80.7%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue9.23M65.18M275.85M275.76M21.74M[{"date":"2019-12-31","value":3.35,"profit":true},{"date":"2020-12-31","value":23.63,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.97,"profit":true},{"date":"2023-12-31","value":7.88,"profit":true}]
Cost of Revenue6.52M38.83M169.72M144.21M12.91M[{"date":"2019-12-31","value":3.84,"profit":true},{"date":"2020-12-31","value":22.88,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.97,"profit":true},{"date":"2023-12-31","value":7.61,"profit":true}]
Gross Profit2.72M26.34M106.13M131.55M8.83M[{"date":"2019-12-31","value":2.06,"profit":true},{"date":"2020-12-31","value":20.03,"profit":true},{"date":"2021-12-31","value":80.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.71,"profit":true}]
Gross Margin29.41%40.42%38.47%47.71%40.61%[{"date":"2019-12-31","value":61.64,"profit":true},{"date":"2020-12-31","value":84.72,"profit":true},{"date":"2021-12-31","value":80.65,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.13,"profit":true}]
Operating Expenses20.94M25.38M116.48M124.88M60.74M[{"date":"2019-12-31","value":16.77,"profit":true},{"date":"2020-12-31","value":20.32,"profit":true},{"date":"2021-12-31","value":93.27,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":48.63,"profit":true}]
Operating Income(18.23M)967.46K(10.35M)207.42M(51.91M)[{"date":"2019-12-31","value":-8.79,"profit":false},{"date":"2020-12-31","value":0.47,"profit":true},{"date":"2021-12-31","value":-4.99,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-25.03,"profit":false}]
Total Non-Operating Income/Expense(2.70M)(2.96M)(165.13M)(164.00M)(4.65M)[{"date":"2019-12-31","value":-269699900,"profit":false},{"date":"2020-12-31","value":-295784100,"profit":false},{"date":"2021-12-31","value":-16512572500,"profit":false},{"date":"2022-12-31","value":-16399785000,"profit":false},{"date":"2023-12-31","value":-464603000,"profit":false}]
Pre-Tax Income(20.87M)(3.90M)(170.28M)(183.31M)(56.67M)[{"date":"2019-12-31","value":-2087267500,"profit":false},{"date":"2020-12-31","value":-390144300,"profit":false},{"date":"2021-12-31","value":-17028409800,"profit":false},{"date":"2022-12-31","value":-18330628300,"profit":false},{"date":"2023-12-31","value":-5666903100,"profit":false}]
Income Taxes(677.47K)(1.94M)3.73M7.15M(269.36K)[{"date":"2019-12-31","value":-9.48,"profit":false},{"date":"2020-12-31","value":-27.11,"profit":false},{"date":"2021-12-31","value":52.23,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-3.77,"profit":false}]
Income After Taxes(20.20M)(1.96M)(174.02M)(190.45M)(56.40M)[{"date":"2019-12-31","value":-2019520100,"profit":false},{"date":"2020-12-31","value":-196388500,"profit":false},{"date":"2021-12-31","value":-17401684200,"profit":false},{"date":"2022-12-31","value":-19045338700,"profit":false},{"date":"2023-12-31","value":-5639967200,"profit":false}]
Income From Continuous Operations(20.20M)(1.96M)(174.02M)(190.45M)(19.11M)[{"date":"2019-12-31","value":-2019520100,"profit":false},{"date":"2020-12-31","value":-196388500,"profit":false},{"date":"2021-12-31","value":-17401684200,"profit":false},{"date":"2022-12-31","value":-19045338700,"profit":false},{"date":"2023-12-31","value":-1911081200,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(20.20M)(1.96M)(174.02M)(190.45M)(62.72M)[{"date":"2019-12-31","value":-2019520100,"profit":false},{"date":"2020-12-31","value":-196388500,"profit":false},{"date":"2021-12-31","value":-17401684200,"profit":false},{"date":"2022-12-31","value":-19045338700,"profit":false},{"date":"2023-12-31","value":-6272387100,"profit":false}]
EPS (Diluted)--(0.08)0.00(1.82)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1986.84,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-47894.74,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PRE
Cash Ratio 0.87
Current Ratio 1.40
Quick Ratio 1.22

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PRE
ROA (LTM) -11.06%
ROE (LTM) -23.80%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PRE
Debt Ratio Lower is generally better. Negative is bad. 0.24
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.76

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PRE
Trailing PE NM
Forward PE NM
P/S (TTM) 2.63
P/B 0.38
EV/R 1.21
EV/Ebitda 0.14
PEG NM

FAQs

What is Prenetics Global Ltd share price today?

Prenetics Global Ltd (PRE) share price today is $5.41

Can Indians buy Prenetics Global Ltd shares?

Yes, Indians can buy shares of Prenetics Global Ltd (PRE) on Vested. To buy Prenetics Global Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PRE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Prenetics Global Ltd be purchased?

Yes, you can purchase fractional shares of Prenetics Global Ltd (PRE) via the Vested app. You can start investing in Prenetics Global Ltd (PRE) with a minimum investment of $1.

How to invest in Prenetics Global Ltd shares from India?

You can invest in shares of Prenetics Global Ltd (PRE) via Vested in three simple steps:

  • Click on Sign Up or Invest in PRE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Prenetics Global Ltd shares
What is Prenetics Global Ltd 52-week high and low stock price?

The 52-week high price of Prenetics Global Ltd (PRE) is $6.99. The 52-week low price of Prenetics Global Ltd (PRE) is $2.85.

What is Prenetics Global Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Prenetics Global Ltd (PRE) is 0.38

What is the Market Cap of Prenetics Global Ltd?

The market capitalization of Prenetics Global Ltd (PRE) is $66.10M

What is Prenetics Global Ltd’s stock symbol?

The stock symbol (or ticker) of Prenetics Global Ltd is PRE

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top